Contrast-induced acute kidney injury.
暂无分享,去创建一个
[1] White blood cell count predicts all-cause mortality in patients with suspected peripheral arterial disease. , 2009, The American journal of medicine.
[2] A. Colombo,et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. , 2004, European heart journal.
[3] H. Dauerman. Percutaneous coronary intervention pharmacology: from a triangle to a square. , 2008, Journal of the American College of Cardiology.
[4] R. Bersin,et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.
[5] E. Cantor,et al. The relative renal safety of iodixanol compared with low-osmolar contrast media. , 2009, JACC. Cardiovascular interventions.
[6] P. Kimmel,et al. Outcomes following diagnosis of acute renal failure in U.S. veterans: focus on acute tubular necrosis. , 2009, Kidney international.
[7] F. Veglia,et al. Contrast Volume During Primary Percutaneous Coronary Intervention and Subsequent Contrast-Induced Nephropathy and Mortality , 2009, Annals of Internal Medicine.
[8] B. Halliwell,et al. Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.
[9] F. Assadi. Acetazolamide for Prevention of Contrast-Induced Nephropathy: A New Use for an Old Drug , 2006, Pediatric Cardiology.
[10] Marino Labinaz,et al. Contrast-induced nephropathy and long-term adverse events: cause and effect? , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[11] M. Joannidis,et al. Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis , 2008, Wiener klinische Wochenschrift.
[12] H. Dauerman. In search of an algorithm to prevent acute kidney injury. , 2009, JACC. Cardiovascular interventions.
[13] S. Bernstein,et al. Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy , 2008, Annals of Internal Medicine.
[14] Gervasio A. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.
[15] J. Gore,et al. Does Comorbidity Account for the Excess Mortality in Patients With Major Bleeding in Acute Myocardial Infarction? , 2007, Circulation.
[16] G. Marenzi,et al. Abstract 4843: Furosemide-induced Diuresis With Matched Replacement of Intravascular Volume Compared to Standard Hydration for Contrast-induced Nephropathy Prevention: The Mythos Trial , 2009 .
[17] P. Teirstein,et al. Safety and Performance of Targeted Renal Therapy: The Be-RITe! Registry , 2009, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.
[18] C. Poole,et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. , 2004, Journal of the American Society of Nephrology : JASN.
[19] Jeremiah R. Brown,et al. Does Safe Dosing of Iodinated Contrast Prevent Contrast-Induced Acute Kidney Injury? , 2010, Circulation. Cardiovascular interventions.
[20] F. Veglia,et al. Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients. , 2006, The American journal of medicine.
[21] J. D'Elia,et al. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. , 1994, The New England journal of medicine.
[22] William W O'Neill,et al. Determinants of serum creatinine trajectory in acute contrast nephropathy. , 2002, Journal of interventional cardiology.
[23] G. Stone,et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.
[24] W. O’Neill,et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy ☆: Results of the P.R.I.N.C.E. study , 1999 .
[25] S. Waikar,et al. Urinary biomarkers in the early diagnosis of acute kidney injury. , 2008, Kidney international.
[26] A. Szabo,et al. High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy. , 2009, The American journal of medicine.
[27] T. Ikizler,et al. Mortality after acute renal failure: models for prognostic stratification and risk adjustment. , 2006, Kidney international.
[28] H. Dauerman,et al. N-acetylcysteine-enhanced contrast provides cardiorenal protection. , 2009, JACC. Cardiovascular interventions.
[29] A. Kastrati,et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. , 2008, Journal of the American College of Cardiology.
[30] P. Teirstein,et al. Differential effects between intravenous and targeted renal delivery of fenoldopam on renal function and blood pressure in patients undergoing cardiac catheterization. , 2006, The American journal of cardiology.
[31] S. Waikar,et al. Creatinine kinetics and the definition of acute kidney injury. , 2009, Journal of the American Society of Nephrology : JASN.
[32] Jeremiah R. Brown,et al. Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: Insights from the Dartmouth Dynamic Registry , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[33] V. Guetta,et al. Reversible Acute Kidney Injury following Contrast Exposure and the Risk of Long-Term Mortality , 2008, American Journal of Nephrology.
[34] H. Gurm,et al. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials. , 2009, JACC. Cardiovascular interventions.
[35] P. McCullough. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes? , 2003, Journal of the American College of Cardiology.
[36] Samin K. Sharma,et al. Cardiac Angiography in Renally Impaired Patients (CARE) Study: A Randomized Double-Blind Trial of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease , 2007, Circulation.
[37] M. Mendenhall. Serious Renal Dysfunction After Percutaneous Coronary Interventions Can be Predicted , 2008 .
[38] W. Bautz,et al. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. , 2009, Radiology.
[39] G. Romano,et al. Contrast agents and renal cell apoptosis. , 2008, European heart journal.